Form 4: Quantum-Si Inc. Executive Acquires Stock Options and Restricted Stock Units

Todd C. Bennett, Chief Commercial Officer of Quantum-Si Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On September 17, 2024, Todd C. Bennett, the Chief Commercial Officer of Quantum-Si Inc., acquired 735,294 stock options with an exercise price of $0.9801.
• These options vest as to 25% on September 20, 2025, and the remainder in 12 equal quarterly installments, contingent on continued service.
• Bennett also acquired 510,152 restricted stock units (RSUs), each representing the right to receive one share of common stock upon vesting.
• These RSUs vest as to 25% on September 20, 2025, with the remainder vesting in 12 equal quarterly installments, also subject to continued service.
• Following these transactions, Bennett directly owns 510,152 shares of Class A Common Stock and 735,294 stock options.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to positive as it indicates confidence in the company's future.

Positives

• The acquisition of stock options and RSUs by a key executive signals confidence in the company's future performance.
• The vesting schedule, tied to continued service, incentivizes the executive to remain with the company.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule suggests a multi-year commitment from the executive.

Industry Context

This type of equity compensation is common in the biotech industry to align executive interests with shareholder value and incentivize long-term growth.

Comparison to Industry Standards

• Equity compensation packages, including stock options and RSUs, are standard practice among publicly traded biotechnology companies like Quantum-Si Inc.
• Companies such as Pacific Biosciences, Oxford Nanopore Technologies, and Illumina also utilize similar compensation strategies to attract and retain key personnel.
• The vesting schedules and amounts granted are generally benchmarked against peer companies to ensure competitiveness and alignment with performance goals.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning executive interests with company performance.
• Employees may see this as a sign of company stability and commitment to its leadership team.

Key Dates